Your browser doesn't support javascript.
Third dose of COVID-19 vaccine restores immune response in patients with haematological malignancies after loss of protective antibody titres.
Susol, Ondrej; Hájková, Barbora; Zelená, Hana; Hájek, Roman.
  • Susol O; Department of Haemato-oncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Hájková B; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Zelená H; Department of Haemato-oncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Hájek R; Institute of Public Health, Ostrava, Czech Republic.
Br J Haematol ; 197(3): 302-305, 2022 05.
Article in English | MEDLINE | ID: covidwho-1714139
ABSTRACT
We have vaccinated 392 patients with two doses of mRNA COMIRNATY vaccine with an overall antibody response of 70% (best in cMPN, worst in CLL). We have then vaccinated 80 patients who did not achieve seroconversion or were low responders with a third dose of COMIRNATY vaccine. Our first results show promise, especially for patients on anti-CD38 therapy.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hematologic Neoplasms / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Br J Haematol Year: 2022 Document Type: Article Affiliation country: Bjh.18073

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hematologic Neoplasms / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Br J Haematol Year: 2022 Document Type: Article Affiliation country: Bjh.18073